Clari Vest Asset Management LLC Puma Biotechnology, Inc. Transaction History

Clari Vest Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$20.07 - $46.7 $277,849 - $646,514	-13,844 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$41.2 - $59.85 $12,730 - $18,493	-309 Reduced 2.18%	13,844 $635,000
Q2 2018 Aug 10, 2018	BUY	$48.3 - $68.25 $141,084 - $199,358	2,921 Added 26.01%	14,153 $838,000
Q1 2018 May 08, 2018	BUY	$59.7 - $99.25 $5,970 - $9,925	100 Added 0.9%	11,232 $764,000
Q4 2017 Feb 13, 2018	BUY	$93.85 - $132.45 $1.04 Million - $1.47 Million	11,132	11,132 $1.1 Million

110

28.3M

27.9K

3.4K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $155M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.